STOCK TITAN

[Form 4] Envista Holdings Corporation Common stock, $0.01 par value per share Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Stefan Nilsson, an officer and director of Envista Holdings Corp (NVST) and listed as President, Nobel Biocare, reported a routine disposition of the issuer's common stock. On 08/25/2025 Code F activity shows 804 shares were disposed at $21.12 per share. The filing explains these shares were withheld to satisfy tax withholding obligations arising from the vesting of stock-settled Restricted Stock Units. After this transaction Nilsson beneficially owned 54,941 shares in a direct ownership form. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.

Stefan Nilsson, dirigente e amministratore di Envista Holdings Corp (NVST) e indicato come President, Nobel Biocare, ha effettuato una disposizione ordinaria di azioni ordinarie dell’emittente. In data 25/08/2025 l’attività classificata come Codice F riporta che sono state cedute 804 azioni a $21,12 per azione. Nel documento si specifica che queste azioni sono state trattenute per soddisfare obblighi fiscali derivanti dalla maturazione di Restricted Stock Units regolate in azioni. Dopo l’operazione, Nilsson deteneva beneficiariamente 54.941 azioni in forma di proprietà diretta. Il Modulo 4 è stato firmato da Heather Turner per delega il 27/08/2025.

Stefan Nilsson, funcionario y director de Envista Holdings Corp (NVST) y registrado como President, Nobel Biocare, informó sobre una disposición rutinaria de acciones ordinarias de la emisora. El 25/08/2025 la actividad con Código F muestra que se dispusieron 804 acciones a $21.12 por acción. La presentación explica que estas acciones fueron retenidas para cubrir obligaciones fiscales surgidas del vencimiento de Restricted Stock Units liquidadas en acciones. Tras esta transacción, Nilsson poseía beneficiosamente 54.941 acciones en propiedad directa. El Formulario 4 fue firmado por Heather Turner por poder el 27/08/2025.

Stefan Nilsson은 Envista Holdings Corp (NVST)의 임원 겸 이사이며 President, Nobel Biocare로 등재된 인물로, 발행회사의 보통주에 대한 일상적인 처분을 보고했습니다. 2025-08-25에 코드 F 활동으로 804주가 주당 $21.12에 처분된 것으로 나타났습니다. 제출서류는 이 주식들이 주식으로 결제되는 제한 주식 단위(RSU)의 베스팅으로 발생한 세금 원천징수 의무를 충족하기 위해 보류되었다고 설명합니다. 이 거래 후 Nilsson은 54,941주를 직접 소유 형태로 실질 보유하고 있었습니다. Form 4는 Heather Turner가 위임장으로 2025-08-27에 서명했습니다.

Stefan Nilsson, dirigeant et administrateur d’Envista Holdings Corp (NVST) et inscrit en tant que President, Nobel Biocare, a déclaré une cession routine d’actions ordinaires de l’émetteur. Le 25/08/2025, l’activité classée Code F indique que 804 actions ont été cédées au prix de 21,12 $ par action. Le dépôt précise que ces actions ont été retenues pour satisfaire des obligations fiscales résultant de la consolidation (vesting) de Restricted Stock Units réglées en actions. Après cette opération, Nilsson détenait bénéficiairement 54 941 actions en propriété directe. Le Formulaire 4 a été signé par Heather Turner par procuration le 27/08/2025.

Stefan Nilsson, ein Offizier und Direktor von Envista Holdings Corp (NVST) und aufgeführt als President, Nobel Biocare, meldete eine routinemäßige Veräußerung von Stammaktien des Emittenten. Am 25.08.2025 weist die Aktivität mit Code F aus, dass 804 Aktien veräußert wurden zu $21,12 pro Aktie. In der Einreichung wird erklärt, dass diese Aktien einbehalten wurden, um steuerliche Abzugsverpflichtungen zu erfüllen, die aus der Vesting von aktienbasierten Restricted Stock Units entstanden sind. Nach dieser Transaktion hielt Nilsson wirtschaftlich 54.941 Aktien in direktem Eigentum. Das Formular 4 wurde am 27.08.2025 von Heather Turner per Vollmacht unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding disposition of vested RSUs; no new purchases or option exercises reported.

This Form 4 documents a common, administrative disposition where 804 shares were withheld to cover taxes on vested restricted stock units. The transaction is classified under Code F and shows a per-share price of $21.12, leaving the reporting person with 54,941 shares directly. There are no derivative transactions or indications of opportunistic open-market trading. For compliance purposes, the filing is complete and signed by a POA.

TL;DR: Non-material insider withholding event; standard reporting practice.

The disclosure indicates an internal withholding to satisfy tax obligations tied to equity compensation rather than a discretionary sale. Such withholding events commonly appear on Form 4s and generally carry neutral governance implications. The remaining direct holding is disclosed as 54,941 shares. The filing includes an authorized signature dated 08/27/2025.

Stefan Nilsson, dirigente e amministratore di Envista Holdings Corp (NVST) e indicato come President, Nobel Biocare, ha effettuato una disposizione ordinaria di azioni ordinarie dell’emittente. In data 25/08/2025 l’attività classificata come Codice F riporta che sono state cedute 804 azioni a $21,12 per azione. Nel documento si specifica che queste azioni sono state trattenute per soddisfare obblighi fiscali derivanti dalla maturazione di Restricted Stock Units regolate in azioni. Dopo l’operazione, Nilsson deteneva beneficiariamente 54.941 azioni in forma di proprietà diretta. Il Modulo 4 è stato firmato da Heather Turner per delega il 27/08/2025.

Stefan Nilsson, funcionario y director de Envista Holdings Corp (NVST) y registrado como President, Nobel Biocare, informó sobre una disposición rutinaria de acciones ordinarias de la emisora. El 25/08/2025 la actividad con Código F muestra que se dispusieron 804 acciones a $21.12 por acción. La presentación explica que estas acciones fueron retenidas para cubrir obligaciones fiscales surgidas del vencimiento de Restricted Stock Units liquidadas en acciones. Tras esta transacción, Nilsson poseía beneficiosamente 54.941 acciones en propiedad directa. El Formulario 4 fue firmado por Heather Turner por poder el 27/08/2025.

Stefan Nilsson은 Envista Holdings Corp (NVST)의 임원 겸 이사이며 President, Nobel Biocare로 등재된 인물로, 발행회사의 보통주에 대한 일상적인 처분을 보고했습니다. 2025-08-25에 코드 F 활동으로 804주가 주당 $21.12에 처분된 것으로 나타났습니다. 제출서류는 이 주식들이 주식으로 결제되는 제한 주식 단위(RSU)의 베스팅으로 발생한 세금 원천징수 의무를 충족하기 위해 보류되었다고 설명합니다. 이 거래 후 Nilsson은 54,941주를 직접 소유 형태로 실질 보유하고 있었습니다. Form 4는 Heather Turner가 위임장으로 2025-08-27에 서명했습니다.

Stefan Nilsson, dirigeant et administrateur d’Envista Holdings Corp (NVST) et inscrit en tant que President, Nobel Biocare, a déclaré une cession routine d’actions ordinaires de l’émetteur. Le 25/08/2025, l’activité classée Code F indique que 804 actions ont été cédées au prix de 21,12 $ par action. Le dépôt précise que ces actions ont été retenues pour satisfaire des obligations fiscales résultant de la consolidation (vesting) de Restricted Stock Units réglées en actions. Après cette opération, Nilsson détenait bénéficiairement 54 941 actions en propriété directe. Le Formulaire 4 a été signé par Heather Turner par procuration le 27/08/2025.

Stefan Nilsson, ein Offizier und Direktor von Envista Holdings Corp (NVST) und aufgeführt als President, Nobel Biocare, meldete eine routinemäßige Veräußerung von Stammaktien des Emittenten. Am 25.08.2025 weist die Aktivität mit Code F aus, dass 804 Aktien veräußert wurden zu $21,12 pro Aktie. In der Einreichung wird erklärt, dass diese Aktien einbehalten wurden, um steuerliche Abzugsverpflichtungen zu erfüllen, die aus der Vesting von aktienbasierten Restricted Stock Units entstanden sind. Nach dieser Transaktion hielt Nilsson wirtschaftlich 54.941 Aktien in direktem Eigentum. Das Formular 4 wurde am 27.08.2025 von Heather Turner per Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nilsson Stefan

(Last) (First) (Middle)
C/O ENVISTA HOLDINGS CORPORATION
200 S. KRAEMER BLVD., BLDG. E

(Street)
BREA CA 92821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Envista Holdings Corp [ NVST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Nobel Biocare
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 F 804(1) D $21.12 54,941 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Remarks:
/s/ Heather Turner, By POA from Stefan Nilsson 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Envista (NVST) report about Stefan Nilsson?

It reported a disposition of 804 shares on 08/25/2025 at $21.12 per share, with 54,941 shares held after the transaction.

Why were the 804 shares disposed of in the NVST Form 4?

The shares were withheld to satisfy tax withholding obligations

What is the transaction code and meaning on this Form 4?

Transaction code F is used; in this filing it corresponds to shares withheld for tax withholding on vested RSUs, as the explanatory note states.

How and when was the Form 4 signed for the NVST filing?

The Form 4 was signed by Heather Turner by power of attorney for Stefan Nilsson on 08/27/2025.

What type of ownership is reported after the transaction?

Direct ownership is reported, with 54,941 shares beneficially owned following the withholding transaction.
Envista Holdings Corp

NYSE:NVST

NVST Rankings

NVST Latest News

NVST Latest SEC Filings

NVST Stock Data

3.53B
164.65M
0.56%
119.73%
5.65%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
BREA